Personalized Medicine - ChemoFit is our intellectual propertyassay in which we take a patient's own solid tumor and disaggregate it into single cells, labeled with stain and subjected to flow cytometry methodology. Thus this heterogenate will contain tumor cells, all stroma cells as well as infiltrating white cells; all of which are important in maintaining the tumor microenvironment and hence response to therapeutic intervention modalities. All types of tumors can be evaluated using our methodology/technology and especially those labeled as an "unknown primary" or have failed conventional therapy a multiple of times. A report will then be generated and send to the physician in a timely manner as to target 1st-line therapy....
Personalized Medicine - ChemoFit is our intellectual propertyassay in which we take a patient's own solid tumor and disaggregate it into single cells, labeled with stain and subjected to flow cytometry methodology. Thus this heterogenate will contain tumor cells, all stroma cells as well as infiltrating white cells; all of which are important in maintaining the tumor microenvironment and hence response to therapeutic intervention modalities. All types of tumors can be evaluated using our methodology/technology and especially those labeled as an "unknown primary" or have failed conventional therapy a multiple of times. A report will then be generated and send to the physician in a timely manner as to target 1st-line therapy.
More information